Trade Names: | |
Synonyms: | |
Status: | Approved (1982) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN Prodrug |
ATC: | D10AD04 |
UNII: | EH28UP18IF |
InChI Key | SHGAZHPCJJPHSC-XFYACQKRSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H28O2 |
Molecular Weight | 300.44 |
AlogP | 5.6 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 37.3 |
Molecular species | ACID |
Aromatic Rings | 0.0 |
Heavy Atoms | 22.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Retinoic acid receptor agonist | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Hydrolase
|
- | - | - | - | 1 | |
Enzyme
Lyase
|
- | - | - | - | 72-96 | |
Other cytosolic protein
|
- | 900-900 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 32 | |
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 37100-37100 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lung Neoplasms | 3 | D008175 | ClinicalTrials |
Brain Neoplasms | 3 | D001932 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Central Nervous System Neoplasms | 3 | D016543 | ClinicalTrials |
Neuroblastoma | 3 | D009447 | ClinicalTrials |
Medulloblastoma | 3 | D008527 | ClinicalTrials |
Kidney Neoplasms | 3 | D007680 | ClinicalTrials |
Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
Uterine Cervical Dysplasia | 3 | D002578 | ClinicalTrials |
Rosacea | 3 | D012393 | ClinicalTrials |
Keratosis, Actinic | 2 | D055623 | ClinicalTrials |
Glomerulosclerosis, Focal Segmental | 2 | D005923 | ClinicalTrials |
Leukemia, Myelomonocytic, Juvenile | 2 | D054429 | ClinicalTrials |
Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
Leukemia | 2 | D007938 | ClinicalTrials |
Tinea Pedis | 2 | D014008 | ClinicalTrials |
Azoospermia | 2 | D053713 | ClinicalTrials |
Emphysema | 2 | D004646 | ClinicalTrials |
Ganglioneuroblastoma | 2 | D018305 | ClinicalTrials |
Klinefelter Syndrome | 2 | D007713 | ClinicalTrials |
HIV Infections | 2 | D015658 | ClinicalTrials |
Multiple Myeloma | 2 | D009101 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Ichthyosis | 2 | D007057 | ClinicalTrials |
Oligodendroglioma | 1 | D009837 | ClinicalTrials |
Infections | 1 | D007239 | ClinicalTrials |
Alzheimer Disease | 1 | D000544 | ClinicalTrials |
Hodgkin Disease | 1 | D006689 | ClinicalTrials |
Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Leukemia, Promyelocytic, Acute | 1 | D015473 | ClinicalTrials |
Burkitt Lymphoma | 1 | D002051 | ClinicalTrials |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
Astrocytoma | 1 | D001254 | ClinicalTrials |
Oligodendroglioma | 1 | D009837 | ClinicalTrials |
Epidermolysis Bullosa | 1 | D004820 | ClinicalTrials |
Gliosarcoma | 1 | D018316 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
Glioma | 1 | D005910 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 4759-48-2 |
ChEBI | 6067 |
ChEMBL | CHEMBL547 |
DrugBank | DB00982 |
DrugCentral | 1508 |
EPA CompTox | DTXSID4023177 |
FDA SRS | EH28UP18IF |
Human Metabolome Database | HMDB0006219 |
Guide to Pharmacology | 7600 |
KEGG | C07058 |
PDB | REA |
PubChem | 5282379 |
SureChEMBL | SCHEMBL38299 |
ZINC | ZINC000003792789 |